Informed Consent

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

A new scale has been developed and validated to examine beliefs held by mental health professionals towards service users’ rights.

Refugees and first-generation immigrants of African descent are at greater risk of experiencing medical coercion when compared to immigrants of other visible minority communities in Canada.

Changing the mental health and psychosocial support system in Germany requires public debate about the ways our society should help and support people in mental crisis and with chronic mental health problems. We believe the driving force behind all help and support should be humanitarianism and respect for inalienable human rights.

Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Gender identity conversion efforts impact psychological distress and lifetime suicidality in transgender people.

Clinicians play a key role in empowering adolescents and their parents to make decisions about their mental health treatment.

After telling my psychotherapist about my medication-fueled suicidal ideation, he said, “You have two options. We can do this either voluntarily or involuntarily.” Aghast and shaken, but assuming everyone in the medical system had my best interests at heart, I reluctantly agreed to go to the hospital without any protest.

At a recent conference on legal capacity, I was struck by the failure of another invited expert to adhere to the paradigm of supported decision-making as articulated by the CRPD Committee. We still need to work to ensure that this paradigm is well understood and appreciated, despite the progress made in national reforms.

Ethnographic research sheds light on extensive psychopharmaceutical use by soldiers in post 9/11 U.S. wars.

Researchers, publishing in Toxicology Research, review the evidence that antidepressant exposure in the womb is linked to autism spectrum disorders (ASD) in humans.

Research illustrates privacy concerns with how mental health applications collect and share users’ data.

A new meta-review examines the experiences of antipsychotic drugs use among people diagnosed with a psychotic disorder.

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.

New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.

Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.

In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.

Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

European citizens from 27 different countries will soon go to the polls to elect their representatives in the European Parliament for the next five years. As an advocacy organisation, we see those elections as an opportunity to call on current and future European leaders and policymakers to bring mental health to the heart of European policies.

“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”

Researchers question the overstated results of a large antidepressant meta-analysis and point to cultural pressures to turn to these drugs for a quick fix.

Researchers identify simple ways for clinicians to begin deprescribing conversations.